

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nucleoside diphosphate phosphorylation (GO:0006165) | 9.01827478 |
| 2 | epithelial cilium movement (GO:0003351) | 8.81905657 |
| 3 | biotin metabolic process (GO:0006768) | 8.79915328 |
| 4 | inflammatory response to antigenic stimulus (GO:0002437) | 7.85050782 |
| 5 | cilium movement (GO:0003341) | 7.64187383 |
| 6 | vocalization behavior (GO:0071625) | 6.39015056 |
| 7 | auditory behavior (GO:0031223) | 6.31468622 |
| 8 | postsynaptic membrane organization (GO:0001941) | 5.99875571 |
| 9 | spindle assembly involved in mitosis (GO:0090307) | 5.98275224 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.73911516 |
| 11 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 5.68026209 |
| 12 | I-kappaB phosphorylation (GO:0007252) | 5.67119950 |
| 13 | negative regulation of fibroblast apoptotic process (GO:2000270) | 5.66653517 |
| 14 | microtubule bundle formation (GO:0001578) | 5.19426360 |
| 15 | tongue development (GO:0043586) | 4.94709823 |
| 16 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 4.75300975 |
| 17 | nucleotide phosphorylation (GO:0046939) | 4.71668618 |
| 18 | mechanosensory behavior (GO:0007638) | 4.69666768 |
| 19 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 4.44905019 |
| 20 | regulation of protein glycosylation (GO:0060049) | 4.35740120 |
| 21 | sphingosine metabolic process (GO:0006670) | 4.30580142 |
| 22 | response to auditory stimulus (GO:0010996) | 4.22489895 |
| 23 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.19198435 |
| 24 | neurotransmitter catabolic process (GO:0042135) | 4.17517796 |
| 25 | sphingoid metabolic process (GO:0046519) | 4.15216231 |
| 26 | renal absorption (GO:0070293) | 4.09440144 |
| 27 | neuron cell-cell adhesion (GO:0007158) | 4.06640964 |
| 28 | microtubule cytoskeleton organization involved in mitosis (GO:1902850) | 4.05708335 |
| 29 | NIK/NF-kappaB signaling (GO:0038061) | 4.01279681 |
| 30 | positive regulation of DNA-templated transcription, initiation (GO:2000144) | 3.98904236 |
| 31 | nucleoside diphosphate metabolic process (GO:0009132) | 3.88639787 |
| 32 | regulation of cellular respiration (GO:0043457) | 3.87020648 |
| 33 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 3.86434661 |
| 34 | diol metabolic process (GO:0034311) | 3.79981960 |
| 35 | positive regulation of heat generation (GO:0031652) | 3.68021456 |
| 36 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.66685009 |
| 37 | regulation of fibroblast apoptotic process (GO:2000269) | 3.64921851 |
| 38 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.64107847 |
| 39 | radial glial cell differentiation (GO:0060019) | 3.54695341 |
| 40 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.52055574 |
| 41 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.46857599 |
| 42 | mating behavior (GO:0007617) | 3.46831330 |
| 43 | regulation of interleukin-13 production (GO:0032656) | 3.38878760 |
| 44 | fibroblast migration (GO:0010761) | 3.32411836 |
| 45 | cellular response to exogenous dsRNA (GO:0071360) | 3.26366188 |
| 46 | regulation of lipoprotein particle clearance (GO:0010984) | 3.25739815 |
| 47 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 3.18580241 |
| 48 | regulation of transcription initiation from RNA polymerase II promoter (GO:0060260) | 3.08250893 |
| 49 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.07390596 |
| 50 | regulation of heat generation (GO:0031650) | 3.04876592 |
| 51 | nephron tubule formation (GO:0072079) | 3.01553357 |
| 52 | facial nerve structural organization (GO:0021612) | 3.00750920 |
| 53 | androgen biosynthetic process (GO:0006702) | 2.99162647 |
| 54 | membrane assembly (GO:0071709) | 2.98430091 |
| 55 | regulation of RIG-I signaling pathway (GO:0039535) | 2.98176468 |
| 56 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.95023260 |
| 57 | regulation of female gonad development (GO:2000194) | 2.90967931 |
| 58 | ruffle organization (GO:0031529) | 2.90051032 |
| 59 | positive regulation of steroid hormone secretion (GO:2000833) | 2.87377271 |
| 60 | glutathione biosynthetic process (GO:0006750) | 2.84498366 |
| 61 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.84171644 |
| 62 | hypothalamus development (GO:0021854) | 2.83566993 |
| 63 | cranial nerve structural organization (GO:0021604) | 2.83525672 |
| 64 | keratinocyte development (GO:0003334) | 2.78581473 |
| 65 | positive regulation of glucose import (GO:0046326) | 2.78571913 |
| 66 | regulation of necroptotic process (GO:0060544) | 2.78233969 |
| 67 | negative regulation of type 2 immune response (GO:0002829) | 2.77261119 |
| 68 | vesicle transport along microtubule (GO:0047496) | 2.73631546 |
| 69 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.72853649 |
| 70 | ovulation cycle (GO:0042698) | 2.72000732 |
| 71 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.71719209 |
| 72 | myelin maintenance (GO:0043217) | 2.71707094 |
| 73 | positive regulation of granulocyte differentiation (GO:0030854) | 2.71459815 |
| 74 | regulation of Rac GTPase activity (GO:0032314) | 2.67307859 |
| 75 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.63987992 |
| 76 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.59452464 |
| 77 | neuronal action potential propagation (GO:0019227) | 2.53371575 |
| 78 | glucosamine-containing compound catabolic process (GO:1901072) | 2.52894031 |
| 79 | positive regulation of isotype switching (GO:0045830) | 2.51580081 |
| 80 | cellular response to reactive nitrogen species (GO:1902170) | 2.51552307 |
| 81 | regulation of triglyceride catabolic process (GO:0010896) | 2.50702735 |
| 82 | necroptotic process (GO:0070266) | 2.50599941 |
| 83 | gland morphogenesis (GO:0022612) | 2.49610300 |
| 84 | peptide biosynthetic process (GO:0043043) | 2.47015392 |
| 85 | glomerular visceral epithelial cell development (GO:0072015) | 2.45700093 |
| 86 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.45687039 |
| 87 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.45465693 |
| 88 | cellular response to zinc ion (GO:0071294) | 2.44570381 |
| 89 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.41049942 |
| 90 | regulation of cellular extravasation (GO:0002691) | 2.40917850 |
| 91 | regulation of DNA-templated transcription, initiation (GO:2000142) | 2.40004252 |
| 92 | positive regulation of glucose transport (GO:0010828) | 2.39718475 |
| 93 | regulation of feeding behavior (GO:0060259) | 2.37918606 |
| 94 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.35904812 |
| 95 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.35849958 |
| 96 | embryonic digestive tract development (GO:0048566) | 2.35481920 |
| 97 | glomerular epithelial cell development (GO:0072310) | 2.34216172 |
| 98 | regulation of natural killer cell activation (GO:0032814) | 2.34090742 |
| 99 | protein carboxylation (GO:0018214) | 2.33767173 |
| 100 | axoneme assembly (GO:0035082) | 10.7508274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.75002418 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.50649322 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.95172200 |
| 4 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.80183720 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.63112660 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.38108705 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.37470968 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.33839550 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30560909 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.25354666 |
| 11 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.19481826 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06333840 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.98366485 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.95880840 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.95880840 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.93328511 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.91197426 |
| 18 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91046923 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.90741311 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.90484871 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.85922499 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62433136 |
| 23 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60845908 |
| 24 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59824714 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57364808 |
| 26 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56690571 |
| 27 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.55870584 |
| 28 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.53955756 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.53254338 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.53042729 |
| 31 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51926735 |
| 32 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.51408395 |
| 33 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50733595 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46289984 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.44208819 |
| 36 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40619416 |
| 37 | P300_19829295_ChIP-Seq_ESCs_Human | 1.33896216 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32463990 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32183515 |
| 40 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.31840639 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31074207 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28087183 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26888326 |
| 44 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26838206 |
| 45 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26838206 |
| 46 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24910017 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24272445 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.21916788 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.19995595 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18928008 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18525104 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18219137 |
| 53 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.17217117 |
| 54 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.16534979 |
| 55 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13772932 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.10371102 |
| 57 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.08956938 |
| 58 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.07652880 |
| 59 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07143569 |
| 60 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05679639 |
| 61 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05512764 |
| 62 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05324426 |
| 63 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02336580 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01771013 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01741104 |
| 66 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01736712 |
| 67 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.00581558 |
| 68 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99929557 |
| 69 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.99277397 |
| 70 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99249979 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98913851 |
| 72 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98487905 |
| 73 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.98206023 |
| 74 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.97852801 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.97506348 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97149733 |
| 77 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96833482 |
| 78 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95089160 |
| 79 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.92704346 |
| 80 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92507913 |
| 81 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.92061057 |
| 82 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91909414 |
| 83 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.91447331 |
| 84 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.90683823 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90522463 |
| 86 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89804296 |
| 87 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89217822 |
| 88 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86829304 |
| 89 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.86203792 |
| 90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.85594580 |
| 91 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.85274581 |
| 92 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.84840106 |
| 93 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84137986 |
| 94 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.81991114 |
| 95 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81325446 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80225370 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80145955 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77514316 |
| 99 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.77468519 |
| 100 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.76181672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002876_abnormal_thyroid_physiology | 5.77973736 |
| 2 | MP0002254_reproductive_system_inflammat | 4.70802201 |
| 3 | MP0005645_abnormal_hypothalamus_physiol | 3.80485304 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.44312981 |
| 5 | MP0001348_abnormal_lacrimal_gland | 3.35822552 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.15682157 |
| 7 | MP0003879_abnormal_hair_cell | 2.97810005 |
| 8 | MP0001346_abnormal_lacrimal_gland | 2.86272005 |
| 9 | MP0000566_synostosis | 2.78201953 |
| 10 | MP0005075_abnormal_melanosome_morpholog | 2.63501340 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.43443825 |
| 12 | MP0004510_myositis | 2.36318826 |
| 13 | MP0004381_abnormal_hair_follicle | 2.26015827 |
| 14 | MP0005670_abnormal_white_adipose | 2.16234362 |
| 15 | MP0006292_abnormal_olfactory_placode | 2.14306688 |
| 16 | MP0001853_heart_inflammation | 2.12052613 |
| 17 | MP0000685_abnormal_immune_system | 2.11643472 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.07694723 |
| 19 | MP0009840_abnormal_foam_cell | 1.88254302 |
| 20 | MP0000920_abnormal_myelination | 1.70154934 |
| 21 | MP0005310_abnormal_salivary_gland | 1.70096334 |
| 22 | MP0008569_lethality_at_weaning | 1.65053430 |
| 23 | MP0009379_abnormal_foot_pigmentation | 1.61537500 |
| 24 | MP0002405_respiratory_system_inflammati | 1.57649144 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 1.44157141 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.43172079 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.43141250 |
| 28 | MP0003303_peritoneal_inflammation | 1.42239040 |
| 29 | MP0002132_abnormal_respiratory_system | 1.41272068 |
| 30 | MP0003959_abnormal_lean_body | 1.40887093 |
| 31 | MP0004859_abnormal_synaptic_plasticity | 1.40821514 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.37687616 |
| 33 | MP0003011_delayed_dark_adaptation | 1.37403180 |
| 34 | MP0004272_abnormal_basement_membrane | 1.36958260 |
| 35 | MP0003315_abnormal_perineum_morphology | 1.30106239 |
| 36 | MP0000751_myopathy | 1.30060766 |
| 37 | MP0005360_urolithiasis | 1.28669491 |
| 38 | MP0005423_abnormal_somatic_nervous | 1.28217944 |
| 39 | MP0000613_abnormal_salivary_gland | 1.23604635 |
| 40 | MP0005187_abnormal_penis_morphology | 1.23377214 |
| 41 | MP0006082_CNS_inflammation | 1.22076085 |
| 42 | MP0008260_abnormal_autophagy | 1.19812874 |
| 43 | MP0003718_maternal_effect | 1.17778069 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.13987450 |
| 45 | MP0002139_abnormal_hepatobiliary_system | 1.13697762 |
| 46 | MP0008874_decreased_physiological_sensi | 1.13415701 |
| 47 | MP0005025_abnormal_response_to | 1.13327721 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.12108105 |
| 49 | MP0004130_abnormal_muscle_cell | 1.10729471 |
| 50 | MP0000579_abnormal_nail_morphology | 1.09583488 |
| 51 | MP0002163_abnormal_gland_morphology | 1.09101071 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.08250030 |
| 53 | MP0001986_abnormal_taste_sensitivity | 1.06079424 |
| 54 | MP0000681_abnormal_thyroid_gland | 1.04435151 |
| 55 | MP0002184_abnormal_innervation | 1.02919326 |
| 56 | MP0004270_analgesia | 1.00312650 |
| 57 | MP0005671_abnormal_response_to | 0.99988342 |
| 58 | MP0002272_abnormal_nervous_system | 0.97410808 |
| 59 | MP0009046_muscle_twitch | 0.96728863 |
| 60 | MP0002269_muscular_atrophy | 0.96450107 |
| 61 | MP0005174_abnormal_tail_pigmentation | 0.95974903 |
| 62 | MP0005085_abnormal_gallbladder_physiolo | 0.94011267 |
| 63 | MP0002419_abnormal_innate_immunity | 0.93380090 |
| 64 | MP0003690_abnormal_glial_cell | 0.92786367 |
| 65 | MP0002971_abnormal_brown_adipose | 0.92072636 |
| 66 | MP0003635_abnormal_synaptic_transmissio | 0.87418534 |
| 67 | MP0009785_altered_susceptibility_to | 0.83732796 |
| 68 | MP0001800_abnormal_humoral_immune | 0.83598756 |
| 69 | MP0003646_muscle_fatigue | 0.81347045 |
| 70 | MP0005332_abnormal_amino_acid | 0.81261368 |
| 71 | MP0005387_immune_system_phenotype | 0.80819721 |
| 72 | MP0001790_abnormal_immune_system | 0.80819721 |
| 73 | MP0003075_altered_response_to | 0.80027573 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 0.75918843 |
| 75 | MP0003136_yellow_coat_color | 0.75449986 |
| 76 | MP0004947_skin_inflammation | 0.74845202 |
| 77 | MP0005379_endocrine/exocrine_gland_phen | 0.73021974 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.72978470 |
| 79 | MP0002970_abnormal_white_adipose | 0.72662609 |
| 80 | MP0009643_abnormal_urine_homeostasis | 0.71611819 |
| 81 | MP0009763_increased_sensitivity_to | 0.69556908 |
| 82 | MP0000609_abnormal_liver_physiology | 0.68354097 |
| 83 | MP0005248_abnormal_Harderian_gland | 0.66114295 |
| 84 | MP0002136_abnormal_kidney_physiology | 0.63924787 |
| 85 | MP0002896_abnormal_bone_mineralization | 0.63602682 |
| 86 | MP0001764_abnormal_homeostasis | 0.63275892 |
| 87 | MP0000470_abnormal_stomach_morphology | 0.63072161 |
| 88 | MP0002998_abnormal_bone_remodeling | 0.62970976 |
| 89 | MP0002452_abnormal_antigen_presenting | 0.62013556 |
| 90 | MP0000428_abnormal_craniofacial_morphol | 0.61230923 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.61174368 |
| 92 | MP0003436_decreased_susceptibility_to | 0.61025558 |
| 93 | MP0001873_stomach_inflammation | 0.60790292 |
| 94 | MP0003634_abnormal_glial_cell | 0.60188298 |
| 95 | MP0001663_abnormal_digestive_system | 0.59667847 |
| 96 | MP0000858_altered_metastatic_potential | 0.59363574 |
| 97 | MP0004134_abnormal_chest_morphology | 0.58033410 |
| 98 | MP0000026_abnormal_inner_ear | 0.57515217 |
| 99 | MP0002102_abnormal_ear_morphology | 0.57279552 |
| 100 | MP0006138_congestive_heart_failure | 0.57142977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.07960707 |
| 2 | Hyperventilation (HP:0002883) | 8.99572946 |
| 3 | Action tremor (HP:0002345) | 8.48430426 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 7.85292891 |
| 5 | Diplopia (HP:0000651) | 7.83064064 |
| 6 | Abnormality of binocular vision (HP:0011514) | 7.83064064 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 7.48254913 |
| 8 | Sensorimotor neuropathy (HP:0007141) | 6.32258037 |
| 9 | Abnormality of the prostate (HP:0008775) | 5.96690600 |
| 10 | Ureteral stenosis (HP:0000071) | 4.71273714 |
| 11 | Cheilitis (HP:0100825) | 4.53208102 |
| 12 | Ureteral obstruction (HP:0006000) | 4.26591601 |
| 13 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.22814433 |
| 14 | Aortic dissection (HP:0002647) | 4.16949361 |
| 15 | Delusions (HP:0000746) | 4.14983177 |
| 16 | Amaurosis fugax (HP:0100576) | 3.96053836 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.95343614 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.81596833 |
| 19 | Osteomalacia (HP:0002749) | 3.80153828 |
| 20 | Obstructive lung disease (HP:0006536) | 3.65905708 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.65905708 |
| 22 | Arterial thrombosis (HP:0004420) | 3.49111085 |
| 23 | Metaphyseal dysplasia (HP:0100255) | 3.38137239 |
| 24 | Joint swelling (HP:0001386) | 3.36528311 |
| 25 | Hypophosphatemic rickets (HP:0004912) | 3.31654341 |
| 26 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.23119089 |
| 27 | Abnormality of male internal genitalia (HP:0000022) | 3.18885026 |
| 28 | Tachypnea (HP:0002789) | 3.07505216 |
| 29 | Pulmonary fibrosis (HP:0002206) | 3.06695036 |
| 30 | Pulmonary infiltrates (HP:0002113) | 3.06336659 |
| 31 | Acrocyanosis (HP:0001063) | 2.96471090 |
| 32 | Type I diabetes mellitus (HP:0100651) | 2.83785953 |
| 33 | Joint hemorrhage (HP:0005261) | 2.73904302 |
| 34 | Chest pain (HP:0100749) | 2.72399247 |
| 35 | Spinal cord compression (HP:0002176) | 2.72072796 |
| 36 | Hyperammonemia (HP:0001987) | 2.65539183 |
| 37 | Gangrene (HP:0100758) | 2.61308530 |
| 38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56192522 |
| 39 | Pulmonary embolism (HP:0002204) | 2.49460764 |
| 40 | Hydroxyprolinuria (HP:0003080) | 2.48331065 |
| 41 | Abnormality of proline metabolism (HP:0010907) | 2.48331065 |
| 42 | Papillary thyroid carcinoma (HP:0002895) | 2.43608402 |
| 43 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.32901386 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.32901386 |
| 45 | Abnormal ciliary motility (HP:0012262) | 2.28401003 |
| 46 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.27521726 |
| 47 | Skin rash (HP:0000988) | 2.27506850 |
| 48 | Meningitis (HP:0001287) | 2.21310025 |
| 49 | Hyperglycemia (HP:0003074) | 2.20410819 |
| 50 | Absent frontal sinuses (HP:0002688) | 2.19884200 |
| 51 | Thrombophlebitis (HP:0004418) | 2.17206843 |
| 52 | Dilatation of the ascending aorta (HP:0005111) | 2.14753655 |
| 53 | Hemoptysis (HP:0002105) | 2.14510906 |
| 54 | Craniofacial hyperostosis (HP:0004493) | 2.09311972 |
| 55 | Depression (HP:0000716) | 2.08497157 |
| 56 | Prolonged partial thromboplastin time (HP:0003645) | 2.07960932 |
| 57 | Type I transferrin isoform profile (HP:0003642) | 2.06277482 |
| 58 | Epistaxis (HP:0000421) | 2.06067599 |
| 59 | Hyperkalemia (HP:0002153) | 2.03093199 |
| 60 | Syringomyelia (HP:0003396) | 2.03090131 |
| 61 | Spinal cord lesions (HP:0100561) | 2.03090131 |
| 62 | Upper limb muscle weakness (HP:0003484) | 2.00499440 |
| 63 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.99588525 |
| 64 | Reduced antithrombin III activity (HP:0001976) | 1.92732620 |
| 65 | Dysmetria (HP:0001310) | 1.86900276 |
| 66 | Abnormality of Sharpey fibers (HP:0100685) | 1.86365297 |
| 67 | Submucous cleft hard palate (HP:0000176) | 1.84967620 |
| 68 | Fragile skin (HP:0001030) | 1.84128759 |
| 69 | Anorexia (HP:0002039) | 1.83783733 |
| 70 | Prostate neoplasm (HP:0100787) | 1.82736448 |
| 71 | Double outlet right ventricle (HP:0001719) | 1.80256675 |
| 72 | Congenital malformation of the right heart (HP:0011723) | 1.80256675 |
| 73 | Tongue fasciculations (HP:0001308) | 1.79827508 |
| 74 | Pancreatitis (HP:0001733) | 1.78735915 |
| 75 | Tibial bowing (HP:0002982) | 1.74968460 |
| 76 | Anxiety (HP:0000739) | 1.74515898 |
| 77 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.73775585 |
| 78 | Thoracic kyphosis (HP:0002942) | 1.73394239 |
| 79 | Gingival bleeding (HP:0000225) | 1.72656049 |
| 80 | Lip pit (HP:0100267) | 1.71676604 |
| 81 | Premature graying of hair (HP:0002216) | 1.71555211 |
| 82 | Polyneuropathy (HP:0001271) | 1.69452133 |
| 83 | Menorrhagia (HP:0000132) | 1.68696616 |
| 84 | Xanthomatosis (HP:0000991) | 1.68405499 |
| 85 | Deep venous thrombosis (HP:0002625) | 1.66452721 |
| 86 | Muscle fibrillation (HP:0010546) | 1.63533404 |
| 87 | Vertigo (HP:0002321) | 1.61502492 |
| 88 | Agammaglobulinemia (HP:0004432) | 1.61035364 |
| 89 | Asymmetry of the thorax (HP:0001555) | 1.60973595 |
| 90 | Restrictive lung disease (HP:0002091) | 1.60331194 |
| 91 | Abnormal pupillary function (HP:0007686) | 1.58706177 |
| 92 | Abnormality of the common coagulation pathway (HP:0010990) | 1.57926976 |
| 93 | Abnormal urine phosphate concentration (HP:0012599) | 1.55736711 |
| 94 | Increased IgM level (HP:0003496) | 1.55503838 |
| 95 | Femoral bowing (HP:0002980) | 1.55352719 |
| 96 | Vasculitis (HP:0002633) | 1.55267710 |
| 97 | Neonatal hypoglycemia (HP:0001998) | 1.54013869 |
| 98 | Recurrent skin infections (HP:0001581) | 1.52379579 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.51035755 |
| 100 | Rickets (HP:0002748) | 1.50829414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK1 | 7.20416031 |
| 2 | TAOK2 | 6.59817418 |
| 3 | MAP3K3 | 4.97099555 |
| 4 | MAP2K3 | 4.82618536 |
| 5 | MAP3K11 | 4.61301176 |
| 6 | NLK | 2.90893193 |
| 7 | TRIB3 | 2.38273892 |
| 8 | DYRK1B | 2.22969635 |
| 9 | TEC | 2.21213253 |
| 10 | ITK | 1.95538434 |
| 11 | MAPK15 | 1.80132930 |
| 12 | FES | 1.77534546 |
| 13 | MAP3K14 | 1.71358533 |
| 14 | PIK3CG | 1.58399916 |
| 15 | TNIK | 1.51090171 |
| 16 | MAP2K7 | 1.50542091 |
| 17 | RIPK4 | 1.48666330 |
| 18 | MAP3K1 | 1.48413539 |
| 19 | MAP3K5 | 1.35142907 |
| 20 | NME2 | 1.34136287 |
| 21 | CASK | 1.33512646 |
| 22 | CDC42BPA | 1.20591850 |
| 23 | TBK1 | 1.10320462 |
| 24 | LMTK2 | 1.07912883 |
| 25 | BTK | 0.99502693 |
| 26 | EIF2AK3 | 0.98735298 |
| 27 | MAP3K13 | 0.95076165 |
| 28 | MST1R | 0.93962839 |
| 29 | BMPR2 | 0.90631943 |
| 30 | PIK3CA | 0.84976030 |
| 31 | GRK1 | 0.84698199 |
| 32 | ILK | 0.83549045 |
| 33 | PRKG1 | 0.80442744 |
| 34 | ERBB3 | 0.78584721 |
| 35 | TIE1 | 0.77445085 |
| 36 | MKNK1 | 0.70647210 |
| 37 | IRAK4 | 0.66780313 |
| 38 | NME1 | 0.64610438 |
| 39 | TAOK3 | 0.63825082 |
| 40 | MAP3K8 | 0.61380102 |
| 41 | PKN1 | 0.60866002 |
| 42 | TGFBR2 | 0.60178352 |
| 43 | IRAK3 | 0.58574681 |
| 44 | NTRK3 | 0.55449031 |
| 45 | DAPK2 | 0.55022992 |
| 46 | ERBB4 | 0.54560341 |
| 47 | MATK | 0.53273323 |
| 48 | CSK | 0.52731874 |
| 49 | PTK2 | 0.52047288 |
| 50 | JAK2 | 0.49160925 |
| 51 | PRKCD | 0.48410420 |
| 52 | GRK5 | 0.47393276 |
| 53 | MARK1 | 0.45288799 |
| 54 | MAP3K7 | 0.45137418 |
| 55 | EPHA4 | 0.44867414 |
| 56 | PKN2 | 0.42234731 |
| 57 | IKBKB | 0.40536430 |
| 58 | NTRK2 | 0.38909809 |
| 59 | JAK1 | 0.34791364 |
| 60 | TTN | 0.34596906 |
| 61 | UHMK1 | 0.34455258 |
| 62 | NTRK1 | 0.33242512 |
| 63 | PTK6 | 0.32509832 |
| 64 | MKNK2 | 0.32324741 |
| 65 | PRKCQ | 0.30501376 |
| 66 | KIT | 0.29809976 |
| 67 | FGR | 0.29052824 |
| 68 | BCR | 0.28849592 |
| 69 | PRKG2 | 0.28468283 |
| 70 | TXK | 0.27501853 |
| 71 | SIK1 | 0.25510026 |
| 72 | YES1 | 0.24476703 |
| 73 | ALK | 0.24121625 |
| 74 | HCK | 0.23873887 |
| 75 | INSRR | 0.23550052 |
| 76 | JAK3 | 0.22886277 |
| 77 | MAPKAPK5 | 0.22771257 |
| 78 | CAMK1D | 0.21566418 |
| 79 | IGF1R | 0.21238751 |
| 80 | EIF2AK2 | 0.19487107 |
| 81 | SRC | 0.19349837 |
| 82 | CAMKK1 | 0.19348947 |
| 83 | PRKAA2 | 0.19071319 |
| 84 | KDR | 0.18989479 |
| 85 | HIPK2 | 0.18379955 |
| 86 | MARK3 | 0.18187480 |
| 87 | OXSR1 | 0.17851262 |
| 88 | PRKACG | 0.17469042 |
| 89 | ROCK2 | 0.17167373 |
| 90 | PIM2 | 0.15680549 |
| 91 | CDK5 | 0.14641025 |
| 92 | STK39 | 0.14380715 |
| 93 | PDGFRB | 0.14156691 |
| 94 | CAMK2A | 0.13523534 |
| 95 | SIK2 | 0.13496444 |
| 96 | SYK | 0.13346431 |
| 97 | FGFR4 | 0.12924226 |
| 98 | PRKCA | 0.12840009 |
| 99 | GRK6 | 0.12804202 |
| 100 | PHKG2 | 0.12360757 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.17690100 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.18494746 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.98893283 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.56781233 |
| 5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.56299691 |
| 6 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.01453255 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.99118739 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.89251720 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.87383881 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.81997030 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.81513852 |
| 12 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72923660 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.59429017 |
| 14 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.54703702 |
| 15 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.51854084 |
| 16 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.46332372 |
| 17 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.43439608 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.42285143 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.37682853 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33000789 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30325853 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.27054529 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.16824308 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15624477 |
| 25 | Melanoma_Homo sapiens_hsa05218 | 1.15503140 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.99408671 |
| 27 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.98559735 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.98552074 |
| 29 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94177442 |
| 30 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92019221 |
| 31 | Tight junction_Homo sapiens_hsa04530 | 0.91301571 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.89385174 |
| 33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.88824851 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88631947 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.87003035 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.86797855 |
| 37 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.85691641 |
| 38 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84540277 |
| 39 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.80766250 |
| 40 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80639864 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 0.79922442 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78134487 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 0.77785283 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.77027545 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76925223 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.76076269 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74631758 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74164382 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72867500 |
| 50 | GABAergic synapse_Homo sapiens_hsa04727 | 0.72510588 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 0.72493217 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69894285 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69796719 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69206569 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67719643 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66708664 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65154453 |
| 58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63678815 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61859786 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.61834522 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61718412 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.61341589 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60717673 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.60659386 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58421274 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.57833766 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.57198134 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56072843 |
| 69 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54244806 |
| 70 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52727200 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52478271 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52079611 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51938390 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.51811868 |
| 75 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50850224 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50655600 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.49348179 |
| 78 | Taste transduction_Homo sapiens_hsa04742 | 0.49076863 |
| 79 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.48982952 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.48532953 |
| 81 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.47949737 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.44775579 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44545938 |
| 84 | Insulin secretion_Homo sapiens_hsa04911 | 0.44459560 |
| 85 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.41423547 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.39919180 |
| 87 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.39481616 |
| 88 | Long-term depression_Homo sapiens_hsa04730 | 0.38883180 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38668814 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.36742245 |
| 91 | Measles_Homo sapiens_hsa05162 | 0.36638737 |
| 92 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36023891 |
| 93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35581615 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.35576639 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34441820 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.34379300 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34083735 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.34068915 |
| 99 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.32359821 |
| 100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31794037 |

